SCHEMBL13716722

SCHEMBL13716722

CCc1cc2cccc(N)c2cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.45
ALDH1A1 P00352 6/20 0.41
CYP3A4 P08684 4/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 3/20 0.41
TSHR P16473 3/20 0.41
KEAP1 Q14145 1/20 0.41
KDM4E B2RXH2 4/20 0.40
TDP1 Q9NUW8 3/20 0.40
POLB P06746 3/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
TDP2 O95551 2/20 0.40
MAPT P10636 2/20 0.40
CASP6 P55212 1/20 0.40
SAE1 Q9UBE0 1/20 0.40
UBA2 Q9UBT2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
F2 P00734 1/20 0.39
PLG P00747 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8296653 0.86 ALDH1A1 (0.41) PARP1ALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL8296655 0.84 ALDH1A1 (0.44) PARP1ALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL5750459 0.81 PARP1 (0.47) PARP1ALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL8312060 0.81 ALDH1A1 (0.50) PARP1ALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL5749223 0.80 PARP1 (0.46) PARP1ALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL14100436 0.79 ALDH1A1 (0.48) PARP1ALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL8291883 0.79 CYP1A2 (0.41) ALDH1A1CYP3A4HPGDHSD17B10KDM4E
SCHEMBL7047251 0.79 HSD17B1 (0.47) KMT2AMEN1PLAUCYP1A2
SCHEMBL8337839 0.79 ALDH1A1 (0.41) PARP1ALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL14100438 0.77 ALDH1A1 (0.44) PARP1ALDH1A1CYP3A4HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427415-B1 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-08-12 EP disclosed